Psoriasis
- PMID: 26025581
- DOI: 10.1016/S0140-6736(14)61909-7
Psoriasis
Abstract
Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease. Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity. Understanding the role of immune function in psoriasis and the interplay between the innate and adaptive immune system has helped to manage this complex disease, which affects patients far beyond the skin. In this Seminar, we highlight the clinical diversity of psoriasis and associated comorbid diseases. We describe recent developments in psoriasis epidemiology, pathogenesis, and genetics to better understand present trends in psoriasis management. Our key objective is to raise awareness of the complexity of this multifaceted disease, the potential of state-of-the-art therapeutic approaches, and the need for early diagnosis and comprehensive management of patients with psoriasis.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis.G Ital Dermatol Venereol. 2010 Jun;145(3):393-406. G Ital Dermatol Venereol. 2010. PMID: 20461047 Review.
-
Overview of psoriasis.Dermatol Ther. 2004;17(5):341-9. doi: 10.1111/j.1396-0296.2004.04037.x. Dermatol Ther. 2004. PMID: 15379769 Review.
-
Psoriasis.J R Coll Physicians Edinb. 2013;43(4):334-8; quiz 339. doi: 10.4997/JRCPE.2013.414. J R Coll Physicians Edinb. 2013. PMID: 24350319 Review.
-
Comorbidities in psoriasis patients.Semin Cutan Med Surg. 2010 Mar;29(1):10-5. doi: 10.1016/j.sder.2010.01.002. Semin Cutan Med Surg. 2010. PMID: 20430302 Review.
-
Psoriasis and systemic inflammation: underdiagnosed enthesopathy.J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1:3-8. doi: 10.1111/j.1468-3083.2009.03361.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19686379 Review.
Cited by
-
Exploratory multi-omics analysis reveals host-microbe interactions associated with disease severity in psoriatic skin.EBioMedicine. 2024 Jul;105:105222. doi: 10.1016/j.ebiom.2024.105222. Epub 2024 Jun 25. EBioMedicine. 2024. PMID: 38924840 Free PMC article.
-
Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris.Int J Mol Sci. 2020 Aug 5;21(16):5617. doi: 10.3390/ijms21165617. Int J Mol Sci. 2020. PMID: 32764517 Free PMC article.
-
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis.Dermatol Ther (Heidelb). 2020 Dec;10(6):1255-1272. doi: 10.1007/s13555-020-00434-3. Epub 2020 Aug 25. Dermatol Ther (Heidelb). 2020. PMID: 32844372 Free PMC article.
-
Gamma Delta T Cells and Their Pathogenic Role in Psoriasis.Front Immunol. 2021 Feb 25;12:627139. doi: 10.3389/fimmu.2021.627139. eCollection 2021. Front Immunol. 2021. PMID: 33732249 Free PMC article. Review.
-
Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis.Front Immunol. 2022 Sep 7;13:937539. doi: 10.3389/fimmu.2022.937539. eCollection 2022. Front Immunol. 2022. PMID: 36159864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical